We are committed to supporting the continual professional development of the cancer care workforce across the alliance and beyond.
In a comprehensive cancer centre setting, leadership means the ability to harness collective effort to achieve maximum gain.
The VCCC develops and supports systems and processes that enable research knowledge to be applied in clinical practice to help ensure that patients benefit quickly from the latest cancer research.
The VCCC Alliance Annual Report 2019-20 highlights the breadth, diversity, and significance of the alliance's work, the potential for future growth, and the impact on the Victorian community.Download a copy of the VCCC Alliance Financial Report 2020.
Future-ready: constant change demands rapid coordination
Intelligent leadership and collaborations, working towards shared goals
Our alliance is a multi-site, multidisciplinary joint venture between 10 leading medical research, academic and clinical institutions with a shared goal of improving outcomes for Victorian patients with cancer.
Consumer engagement is integral to all VCCC programs, creating opportunities for collaboration across the alliance, and reinforcing our ethos to keep patient experiences at the forefront of our thinking.
Increasing disciplines, efficiencies and resources, to expand patient access, diversify workforce skills and implement new approaches.
As an alliance organisation, our ability to bring about better connectivity is key to the effective integration of research, education and clinical translation.
Harnessing expertise in innovative ways to help translate leading-edge knowledge into contemporary learning.
The strength and future of this alliance is the deep pool of talent that it brings together.
Developing and supporting systems and processes that enable research knowledge to be applied in clinical practice and ensure that patients benefit quickly from the latest cancer research.
Collaborations have generated a range of new tools and resources; promoting dissemination of information and increasing capability across the sector.
2017-2020: accelerating translation of research and driving better outcomes for patients with cancer.